Concentrix is trading at $22.11 (5.4% up) as shares recover from a sharp selloff triggered by a trimmed 2026 financial outlook and index-related changes.

  • The company recently lowered its full-year 2026 revenue and EPS guidance, pointing to macroeconomic pressures and client weakness.
  • The stock is seeing a recovery as investors reassess the impact of the earlier downgrade-driven move.